Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3282351 | Clinical Gastroenterology and Hepatology | 2012 | 8 Pages |
Abstract
Hydroxychloroquine, 100 mg twice weekly, is as effective and safe as phlebotomy in patients with PCT, although noninferiority was not established. Given these results, higher-dose regimens of hydroxychloroquine, which have more side effects, do not seem justified. Compliance was better and projected costs were lower for hydroxychloroquine than phlebotomy treatment. Long-term studies are needed to compare durability of response. ClinicalTrials.gov number, NCT01573754.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Ashwani K. Singal, Csilla Kormos-Hallberg, Chul Lee, Vaithamanithi M. Sadagoparamanujam, James J. Grady, Daniel H. Jr, Karl E. Anderson,